Chongqing Kangle Pharmaceutical Co., Ltd. was established in January 1988 and is located at No. 4 Huazhong Avenue, Changshou Economic and Technological Development Zone, Chongqing, a national park. It is controlled by Huakong Kangtai Group Co., Ltd., a Hong Kong listed company under Shenzhen Huarongtai Asset Management Co., Ltd. (stock code HK.01312) and is under Shanxi Construction Investment Group Co., Ltd.
 
Kangle Pharmaceutical is a research and development base mainly engaged in chemical synthesis of raw materials and pharmaceutical intermediates. The products are exported to multiple regions around the world and widely recognized in the international pharmaceutical market, with a good reputation. The company's products involve antimalarial drugs, psychiatric drugs, anti rheumatic drugs, cardiovascular drugs, anti-tumor drugs, urological drugs, drug intermediates, etc. There are currently 258 employees, of which 25% are professional and technical personnel. The company is market-oriented and driven by technological innovation, vigorously promoting product exports and high-tech project research and development.

The company has obtained 6 key new products and 12 high-tech products; There are 2 technological innovation projects, 2 scientific and technological research projects, and 6 science and technology plan projects in Changshou District in Chongqing. The company has 151 patents, including 91 invention patents and 60 utility model patents, and has been granted 10 invention patents and 60 utility model patents; Received 2 third prizes for scientific and technological progress and 1 second prize for scientific and technological progress; 24 scientific and technological achievements have been registered. Rated as "Chongqing Key Support for Small and Medium sized Enterprises", "Star level Cultivation Project" of Innovation Fund, the first batch of "Four Star" Cultivation Enterprises, Advanced Collective in Technological Innovation, Advanced Collective in Science and Technology Work, Demonstration Production Enterprise, Outstanding Enterprise in Innovation Work, Chongqing Intellectual Property Pilot Unit, City level Intellectual Property Advantage Enterprise, and National High tech Enterprise. It is a teaching internship base of Tsinghua University and a national intellectual property advantage enterprise.

The company has a complete quality management system, and its products have obtained national drug registration approval and passed GMP certification. Multiple products have been certified by the US FDA, Japan PMDA, as well as the World Health Organization WHO and PQ. Our company's products are exported to countries or regions such as the United States, Europe, Japan, South America, and Southeast Asia.

The company has established a comprehensive HSE management system and set up a dedicated HSE management department. Obtained certificates such as Chongqing Pollutant Discharge Permit, Safety Production Permit, and Safety Standardization Enterprise. The company attaches great importance to environmental protection, safety, occupational health, and social responsibility, adheres to the concept of people-oriented, and values the health and safety of employees. Since the establishment of the company, there have been no major quality, environmental, or safety production responsibility accidents.

The company has established a sound financial management system and conducts corporate financial management in accordance with national laws and regulations. It has also established a good cooperative relationship with banks and has a good corporate reputation.